Ambrx Biopharma Inc (NYSE:AMAM)
| 1.80 Delayed Data As of Feb 03 |  0.00 / 0.00%Today’s Change | 0.38 Today|||52-Week Range 5.12 | -20.70% Year-to-Date |
Latest AMAM News | Press Releases
No recent news for Ambrx Biopharma Inc.
Today’s Trading
| Previous close | 1.80 |
| Today’s open | 1.87 |
| Day’s range | 1.76 - 1.90 |
| Volume | 330,995 |
| Average volume (3 months) | 2,590,666 |
| Market cap | -- |
Data as of 3:59pm ET, 02/03/2023
Growth & Valuation
| Earnings growth (last year) | -312.87% |
| Earnings growth (this year) | +50.00% |
| Earnings growth (next 5 years) | +65.33% |
| Revenue growth (last year) | -45.47% |
| P/E ratio | 0.3 |
| Price/Sales | 46.74 |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Last reporting date | June 1, 2022 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $7.5M |
| Annual profit (last year) | -$68.1M |
| Net profit margin | -913.20% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
